哮喘是世界第二致死致残疾病 我国控制率仅为28.3%

2018-05-10 刘昶荣 中国青年报

“哮喘是慢性疾病,很难彻底根治。在管理哮喘的过程中,专科医生只能起到20%的作用,剩下的80%需要患者自己完成。”近日,在中国哮喘联盟召开的2018世界哮喘日新闻发布会上,中国哮喘联盟总负责人、国务院政府特殊津贴享受者、中日友好医院呼吸内科主任林江涛一句话总结了患者在管理哮喘过程中的重要作用。


“哮喘是慢性疾病,很难彻底根治。在管理哮喘的过程中,专科医生只能起到20%的作用,剩下的80%需要患者自己完成。”近日,在中国哮喘联盟召开的2018世界哮喘日新闻发布会上,中国哮喘联盟总负责人、国务院政府特殊津贴享受者、中日友好医院呼吸内科主任林江涛一句话总结了患者在管理哮喘过程中的重要作用。

5月1日是第20个世界哮喘日,今年哮喘日的主题是“重视气道疾病防治:从现在开始”。近年来,哮喘的患病率在全球范围内逐年增加。据估计,目前全球哮喘患者至少在3亿人以上,我国有3000万哮喘患者。截至目前,哮喘仍是世界公认的医学难题,被世界卫生组织列为疾病中的四大顽症之一,它也成为仅次于癌症的世界第二大致死和致残疾病。

林江涛及其课题组于2016年完成的“全国城区哮喘患者控制现状和疾病认知程度的调查(CARN-2015-01)”显示,我国哮喘患者中仅有28.3%实现了完全控制,71.7%的哮喘患者控制水平有待提高。可见,我国哮喘患者的整体控制率并不乐观。据了解,此次调查覆盖我国30个省(区、市),共有3875例门诊患者纳入其中。

随意减药、停药,容易导致哮喘复发

哮喘(支气管哮喘)是一种呼吸道的慢性炎症疾病,长期存在。表现为发作性咳嗽、胸闷及呼吸困难。呼吸道的这种炎症程度越重,正常呼吸就越困难。如果没有采取任何抗炎措施,将会导致支气管阻塞或挛缩,甚至可能因呼吸困难而危及生命。

调查显示,因哮喘控制不佳,成人的误工率达18.4%,而青少年作为哮喘的高发人群,其误学率高达63.6%。此次调查虽然没有涉及农村,但是根据林江涛的临床经验,近几年,哮喘在城区的发病情况比农村略微严重。

林江涛表示,哮喘虽然很难彻底根治,但是患者如果规范管理,坚持用药,定期随诊,哮喘完全能得到良好的控制。

3月和9月是哮喘疾病的高发期,根据《我国城区支气管哮喘急性发作住院患者治疗情况的调查分析》显示,哮喘急性发作住院患者中,仅28%的患者平时规律服用哮喘治疗药物。林江涛介绍说,未控制的哮喘导致卫生资源使用率高,包括频繁住院、急诊次数增加和医疗费用增加。

南京医科大学第一附属医院呼吸科主任医师、国务院政府特殊津贴享受者殷凯生介绍说,有些患者通过一段时间的治疗,哮喘得到了有效控制,他们便放松警惕,不再持续用药,这反而导致了哮喘的复发。他指出,患者在未征询主治医生意见的情况下,不擅自减少药量或停药,这样才能将哮喘控制到最好。

理性用药,谨防偏方和假药

值得注意的是,并不是所有的气喘都由哮喘引发,急性和慢性左心功能不全、自发性气胸、慢阻肺病等众多疾病也会有气喘的症状。对于诊断过程中可能出现的差错,殷凯生指出,经过正规治疗,疗效仍然不佳的哮喘病人应该提高警惕,寻求进一步的医疗诊断

拥有近50年临床经验的殷凯生介绍说,他在门诊中遇到很多患者都希望可以彻底根治哮喘,这是治疗目标定位的不准确,哮喘和慢性胃炎、高血压糖尿病等一样,是无法根治的疾病。

正是因为患者建立了错误的治疗目标,导致了大量打着“根治哮喘”“祖传根治哮喘单方”等夸大其辞的偏方和没有国药准字号的假药有了生存市场,这个现象在农村更为严重。殷凯生建议哮喘患者要到正规医疗单位就医,以免耽误治疗的最佳时机,导致哮喘急性发作住院。

至于治疗哮喘的有效药物,殷凯生指出吸入糖皮质激素是公认的最有效药物,也是治疗哮喘的基础和一线药物。但是由于很多患者担心激素的副作用,导致药物选择不当、剂量不足和疗程过短,殷凯生强调:“激素属于‘久久为功’的药物,长期服用后才能产生应有的效果。”

此外,殷凯生还表示,由于吸入制剂是局部给药,药物主要通过消化道和呼吸道进入血液,大部分药物被肝脏灭活,全身的副作用相对小得多。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 ann y

    哮喘是世界第二致死致残疾病

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 ann y

    哮喘是世界第二致死致残疾病

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 ann y

    哮喘是世界第二致死致残疾病

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 ann y

    哮喘是世界第二致死致残疾病

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-13 ann y

    哮喘是世界第二致死致残疾病

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1641390, encodeId=2ad116413901c, content=<a href='/topic/show?id=49ba864598c' target=_blank style='color:#2F92EE;'>#致残#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86459, encryptionId=49ba864598c, topicName=致残)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2622802899, createdName=ms7421025882867189, createdTime=Tue Aug 14 09:12:00 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058994, encodeId=b87e20589949c, content=<a href='/topic/show?id=d0d78646297' target=_blank style='color:#2F92EE;'>#致残疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86462, encryptionId=d0d78646297, topicName=致残疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad7f282, createdName=yang0210, createdTime=Thu Jun 07 09:12:00 CST 2018, time=2018-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314788, encodeId=aa21314e8887, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:37 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314787, encodeId=f669314e87fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:31 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314786, encodeId=5100314e86fe, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:26 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314785, encodeId=12b9314e853b, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:19 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314784, encodeId=4f82314e84f9, content=哮喘是世界第二致死致残疾病 , beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRrYOibkVibW9vAkCfb2F55aHjqMoqUVaF9fuXIMCxexawSOsicpbF7Ria7o54zPK65PodlkwhPrNhLhS/0, createdBy=12f71314239, createdName=ann y, createdTime=Sun May 13 20:59:14 CST 2018, time=2018-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313969, encodeId=7790313969f9, content=学习了 非常感谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35e76003, createdName=871538379, createdTime=Fri May 11 05:11:16 CST 2018, time=2018-05-11, status=1, ipAttribution=)]
    2018-05-11 871538379

    学习了 非常感谢

    0

相关资讯

Semin Arthritis Rheu:女性类风湿性关节炎和COPD、哮喘的发病风险

在这项前瞻性队列研究中,RA与偶发性COPD风险升高相关,与生活方式混杂因素和包括吸烟在内的诊断后介质无关。

JAMA:对于持续性哮喘患者,LAMA 是ICS的得力助手吗?

2018年4月,发表在《JAMA》的一项由美国科学家进行的系统评价和Meta分析,考察了未控制的持续性哮喘患者中,吸入性糖皮质激素(ICS)和长效毒蕈碱受体拮抗剂(LAMA)与哮喘控制的相关性。

J Asthma:秋天花粉诱导的过敏性鼻炎中,血清特异性lgE水平与哮喘相关性研究

艾草和葎草花粉在中国北方是2中最为重要的秋季过敏过敏原。在2001年的代表性数据表明了过敏性鼻炎总是领先或者是同时和中国北方的秋季花粉过敏病人哮喘发生。最近,有研究人员利用代表性的数据调查了血清特异性lgE (slgE)水平与葎草和/或艾草花粉的相关性,时间点事秋季花粉诱导的过敏性鼻炎患者哮喘开始时。研究包括了1096名秋季花粉病患者,并且进行了面对面交谈和对葎草和艾草的slgE测试,阐释和记录了

专家建议:控制哮喘是场持久战,要学会与哮喘病“和平共处”

2018年5月1日是第二十个“世界哮喘日”,今年哮喘日的主题是“重视气道疾病防治:从现在开始”。

JAMA:持续性哮喘患者 哪种治疗方案能防止哮喘加重?

2018年4月,发表于《JAMA》上的一项系统评价和Meta分析,考察了吸入性糖皮质激素和长效β-受体激动剂(LABA)作为控制治疗和快速缓解治疗与持续性哮喘患者哮喘加重和症状控制的相关性。

Allergy Asthma Proc:过敏性鼻炎和花粉过敏儿童中,关于哮喘在围产期风险因子的研究

流行病学研究结果确定了学龄期儿童哮喘的一些风险因子。最近,有研究人员为了调查是否父母和围产期风险因子、以及婴儿的喂养方式与患有花粉过敏和过敏性鼻炎儿童的哮喘相关。研究包括了293名儿童(200名男孩(68.3%)),平均年龄为10.2岁(范围为7.4到13岁)。总共有109名儿童(37.2%)患有伴随的哮喘。在患有哮喘的儿童中,鼻炎症状的起始平均年龄更小(5.3岁 [IQR, 4.0-8.0 岁]